Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.

Journal of Alzheimer's disease : JAD - 1 Jan 2017

Hong Honghai, Li Yang, Su Baochang

Abstract excerpt

Alzheimer's disease (AD) is the most common form of dementia, characterized by progressive decline in cognitive abilities of the affected individuals. Biological markers are essential to identify individuals at early stages of the disease for timely therapeutic intervention. Currently, pathological biomarkers are detected either through cerebrospinal fluid analysis or brain imaging, or postmortem, all of which...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Protein Precursor
Share to Analysis of Variance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Catechin

Share to Cognition Disorders

Share to Maze Learning

Share to Neuroblastoma

Share to Presenilin-1

Share to Protease Inhibitors

Source

Identifiers

PMID: 28731435
DOI: 10.3233/JAD-170156

Genes

APP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.PMID 28731435Read ↗

Genome-Wide Analysis of miRNA Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's DiseaseSemantic proximity Read ↗

MicroRNA‑125b regulates Alzheimer's disease through SphK1 regulationSemantic proximity Read ↗

The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's DiseaseSemantic proximity Read ↗

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s DiseaseSemantic proximity Read ↗

Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s diseaseSemantic proximity Read ↗

A New Discovery of MicroRNA-455-3p in Alzheimer’s DiseaseSemantic proximity Read ↗

Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer’s DiseaseSemantic proximity Read ↗

miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1qSemantic proximity Read ↗

MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer’s diseaseSemantic proximity Read ↗

Exosomal MicroRNAs modulate the cognitive function in fasudil treated APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer's diseaseSemantic proximity Read ↗

miR-519a-3p, found to regulate cellular prion protein during Alzheimer’s disease pathogenesis, as a biomarker of asymptomatic stagesSemantic proximity Read ↗

MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.